Hillenbrand Inc (HI) Stock News

Hims & Hers Health (NYSE: HIMS) faces a securities class action lawsuit following an FTC complaint alleging the company deceptively shared consumers' health data with third-party advertising platforms like Meta and Snap, and violated billing regulations by charging for prescriptions before medical consultations. The stock plunged 14.7% on July 29, 2026, erasing over $970 million in market value.

Rosen Law Firm has filed securities class action lawsuits against Hims & Hers Health, Duolingo, and Ardelyx. The Hims lawsuit alleges the company made false statements regarding data privacy practices, prescription charging procedures, and failed to disclose regulatory scrutiny and potential penalties. Investors who purchased securities during specified class periods are encouraged to join the litigation before the November 2, 2026 lead plaintiff deadline.

Seanergy Maritime Holdings Corp (SHIP) gained 2.26% to close at $17.63, outperforming a declining market. The company is expected to report EPS of $0.77 (up 14.93% YoY) with revenue forecasted at $50.69 million (up 7.87% YoY). For the full year, analysts project EPS of $3.57 and revenue of $201.97 million, representing significant growth. SHIP currently holds a Zacks Rank #3 (Hold) with a Forward P/E of 4.83, trading at a discount to its industry average.

Innovayte, a custody and clearing firm for registered investment advisors, announced the appointment of Fritz Louis-Charles as Chief Operating Officer. Louis-Charles brings over 20 years of financial services experience, including previous roles as COO of Apex Fintech Solutions and leadership positions at JPMorgan Chase and TD Ameritrade. He will oversee enterprise-wide operations and help guide the firm's next growth phase.

Holzer & Holzer, LLC announced lead plaintiff deadlines for shareholder class action lawsuits against Unicycive Therapeutics, Hims & Hers Health, and Beta Bionics. The lawsuits allege materially false statements and non-disclosure of material facts regarding regulatory risks, deceptive billing practices, data sharing, and device safety issues. Investors who purchased shares during specified periods and suffered losses are encouraged to seek lead plaintiff status by November 2-3, 2026.

Rosen Law Firm is reminding investors who purchased Tigo Energy securities between February 24, 2026 and August 4, 2026 of the November 23, 2026 deadline to join a securities class action lawsuit. The lawsuit alleges that Tigo made materially false and misleading statements regarding revenue projections based on an EG4 partnership that would not generate material revenue until Q4 2026 at the earliest, lacking a reasonable basis for the projections.

Rosen Law Firm is soliciting investors who purchased securities of Hims & Hers Health, Inc. between August 4, 2025 and July 29, 2026 to join a class action lawsuit. The lawsuit alleges that Hims made materially false statements regarding data privacy practices, prescription charging procedures, and regulatory compliance, which subjected the company to potential fees and penalties.

Rosen Law Firm has filed class action lawsuits against Qfin Holdings, Inc. and Anavex Life Sciences Corp. on behalf of investors who purchased securities during specified periods. The Qfin lawsuit alleges defendants made false statements about business resilience and downplayed regulatory impacts. Investors have until November 30, 2026 to move the court to serve as lead plaintiff.

D.R. Horton (DHI) closed at $133.23, down 1.31% and lagging market gains. The homebuilder has dropped 5.43% over the past month. While trading at a discount with a Forward P/E of 11.57, the company faces headwinds with a Zacks Rank #4 (Sell) rating. Consensus estimates show a 0.66% EPS increase but a 6.66% revenue decline for the upcoming quarter, with annual projections showing -9.59% earnings decline and -4.18% revenue decrease. The Building Products - Home Builders industry ranks in the bottom 3% of all industries.

Vallourec announces the appointment of Isabelle Quéméneur as Group Chief Digital and Information Officer, effective October 5, 2026. Quéméneur, previously Chief Technology Officer at Danone, joins Vallourec's Executive Committee to lead digital transformation initiatives focused on customer value creation and modernizing team operations in response to cybersecurity and AI challenges.

A securities class action lawsuit has been filed against Hims & Hers Health, Inc. for allegedly making materially false and misleading statements regarding consumer data sharing with third-party advertising platforms, charging for prescriptions before medical consultations, and failing to disclose regulatory scrutiny and potential penalties. The lead plaintiff deadline is November 2, 2026.

Kaplan Fox has filed a securities class action lawsuit against Hims & Hers Health, Inc. (NYSE: HIMS) on behalf of investors who purchased securities between August 4, 2025 and July 29, 2026. The FTC sued the company for allegedly failing to disclose immediate prescription charges, making subscription cancellations difficult, and sharing consumers' health information with third-party advertising platforms like Meta and Snap. The stock fell 14.73% to $25.00 per share following the FTC action. The lead plaintiff deadline is November 2, 2026.

Schall, Brown & Schwartz LLP announces a securities fraud class action lawsuit against Hims & Hers Health, Inc. for making false and misleading statements regarding customer health data sharing with third-party advertising platforms and treatment practices that could trigger regulatory scrutiny. The class period spans August 4, 2025 to July 29, 2026, with a November 2, 2026 deadline for investors to participate.

Robbins Geller Rudman & Dowd LLP announced a class action lawsuit against Hims & Hers Health, Inc. following FTC allegations that the telehealth provider shared consumers' sensitive health information with third-party advertising platforms including Meta and Snap, and engaged in deceptive billing practices. The lawsuit covers securities purchased between August 4, 2025 and July 29, 2026, with a lead plaintiff deadline of November 2, 2026. Hims & Hers shares declined nearly 15% following the FTC announcement.

Law Offices of Howard G. Smith has filed securities fraud class action lawsuits against four publicly-traded companies: Hyliion Holdings Corp., Hims & Hers Health Inc., Unicycive Therapeutics Inc., and Baidu Inc. The lawsuits allege that defendants made materially false and misleading statements and failed to disclose material adverse facts about their respective businesses. Investors have until specified deadlines in late October and November 2026 to file lead plaintiff motions.

Dimensional Fund Advisors Ltd. has disclosed a position of 277,711 EUR 1 ordinary shares (0.59%) in RHI Magnesita NV as of September 30, 2026. The disclosure was made on October 1, 2026, in connection with a takeover-related filing. Dimensional also made concurrent disclosures regarding Vesuvius PLC. The fund advisor purchased 369 shares at 29.3988 GBP per unit during the disclosure period.

Hims & Hers Health faces a securities class action lawsuit after the FTC alleged the telehealth provider shared consumers' sensitive health information with third-party advertising platforms and engaged in deceptive billing practices. The stock fell 14.73% to $25.00 on July 29, 2026, following the FTC announcement. Investors with losses exceeding $100,000 have until November 2, 2026 to file lead plaintiff applications.

USS Harry S. Truman (CVN 75) arrived at HII's Newport News Shipbuilding on September 30, 2026, to begin its refueling and complex overhaul (RCOH). The project represents a major mid-life maintenance and modernization effort for the eighth Nimitz-class carrier to undergo this availability. HII was awarded a $5.1 billion contract to execute the work, which includes hull repairs, propeller maintenance, and nuclear refueling.

Hims & Hers Health (HIMS) faces a securities class action lawsuit following an FTC complaint alleging the company shared consumers' health data with third-party advertisers like Meta and Snap, charged for prescriptions before medical consultations, and violated ROSCA regulations. The stock dropped 14.7% on July 29, 2026, erasing over $970 million in market value. Investors with substantial losses are encouraged to participate in the class action.

Seanergy Maritime Holdings (SHIP) has underperformed the broader market with a -8.8% return over the past month, despite beating earnings and revenue estimates in recent quarters. The company shows strong current year earnings growth of +178.9% but faces a projected decline of -44.5% in the next fiscal year. With a Zacks Rank #3 (Hold) rating and a Grade A valuation score indicating the stock trades at a discount to peers, the stock is expected to perform in line with the broader market in the near term.

HII has been awarded a U.S. Navy contract to build 10 ROMULUS unmanned surface vessels (USVs) for the Medium Unmanned Surface Vessel (MUSV) program. The contract marks a significant milestone in transitioning autonomous maritime systems from experimentation to fleet-scale operational deployment. HII is leveraging its Odyssey Autonomous Control Solutions and a distributed production model with regional Gulf Coast partners to deliver the vessels at scale.

The FTC filed a lawsuit against Hims & Hers Health, Inc. on July 29, 2026, alleging the telehealth provider shared consumers' sensitive health information with third-party advertising platforms while claiming to maintain privacy, and deceived users about billing and cancellation practices. The stock declined 14.73% on the news. A class action lawsuit has been filed, with a November 2, 2026 deadline for investors to file lead plaintiff motions.

Faruqi & Faruqi, LLP is investigating potential securities fraud claims against Wise Group plc (NASDAQ: WSE), alleging the company made false and misleading statements about its anti-money laundering and counter-terrorism financing compliance efforts ahead of its NASDAQ debut. Investors who purchased Wise securities between May 11, 2026 and July 23, 2026 have until September 29, 2026 to seek lead plaintiff status in the federal class action lawsuit.

A securities class action lawsuit has been filed against Pentair plc alleging the company made false statements about its business prospects while failing to disclose significant inventory destocking in its Pool channel. The undisclosed destocking negatively impacted Pool segment sales by approximately $170 million and income by $105 million in Q2 2026, causing the stock to fall 15% on July 15, 2026. Investors who purchased Pentair securities between March 11, 2025 and July 14, 2026 have until October 2, 2026 to seek lead plaintiff status.

Faruqi & Faruqi, LLP is investigating securities fraud claims against Capricor Therapeutics for allegedly making misleading statements about its Deramiocel drug's regulatory prospects. The company allegedly failed to disclose changes to its statistical analysis plan and lack of FDA agreement before resubmitting the Biologics License Application. Capricor's stock plummeted 64% on July 27, 2026, after the FDA released unfavorable briefing documents, and fell an additional 36% on July 30, 2026, following an AdCom panel's 9-3 vote against the drug's efficacy. Investors who purchased securities between December 17, 2025 and July 26, 2026 may be eligible to participate in the class action lawsuit, with a September 28, 2026 deadline to seek lead plaintiff status.

A securities class action lawsuit has been filed against Rackspace Technology for allegedly misleading investors about the financial impact of its AI strategy, declining Public Cloud revenue, and reduced infrastructure resale business. The company reduced its full year 2026 revenue guidance by $150 million on July 9, 2026, causing its stock to fall 33.6%. The deadline to seek lead plaintiff status is September 28, 2026.

Faruqi & Faruqi, LLP is investigating securities fraud claims against Bloom Energy Corporation, alleging the company made false statements about its supply chain by understating reliance on Chinese scandium sourced through intermediaries. Following a July 8, 2026 report by Hunterbrook Media exposing the company's China-linked supply routes, Bloom Energy's stock fell 5.7%. Investors who purchased securities between February 27, 2025 and July 8, 2026 have until September 28, 2026 to seek lead plaintiff status in the class action lawsuit.

A securities class action lawsuit has been filed against Blaize Holdings, Inc. (NASDAQ: BZAI) alleging that the company made false and misleading statements about revenue recognition and announced transactions with unequipped entities to artificially boost growth. The allegations were highlighted by a Pelican Way Research report on April 28, 2026, which claimed Blaize engaged in a bogus deal with a 4-month-old counterparty, causing the stock to fall 12.03% that day. Investors who purchased Blaize securities between July 18, 2025 and April 28, 2026 have until October 5, 2026 to seek lead plaintiff status.

Rosen Law Firm is soliciting investors who purchased Hims & Hers Health securities between August 4, 2025 and July 29, 2026 to join a class action lawsuit. The lawsuit alleges that Hims made materially false statements regarding data privacy practices, prescription charging procedures, and regulatory compliance, leading to investor damages when the true details became public.

A securities fraud class action lawsuit has been filed against Hims & Hers Health, Inc. for allegedly making materially false statements about its privacy practices. The FTC accused HIMS of sharing customers' medical information with third-party advertisers including Meta and Snap, and charging consumers for prescriptions without proper consultation. The stock declined 14.73% on the news, dropping $4.32 per share to $25.00 on July 29, 2026.